Research description:
Cancer complexity makes it difficult to treat. Precision medicine targets driver mutations, but many driver combinations in different cancer clones complicate this approach. An alternate is to deduce overarching rules that cancer cells obey. Taking this route, we simplified all cancers into binary classes based on the opposite expression and function of a single coactivator, YAP. In YAPoff cancers YAP is epigenetically silenced because it induces growth arrest, contrasting YAPon cancers, where YAP is essential for cell division. Cancers can jump binary classes to evade therapy e.g. YAPon prostate or lung adenocarcinoma switch to untreatable and lethal YAPoff neuroendocrine cancer. We aim to develop a machine learning classifier that can be used clinically to distinguish YAPoff vs YAPon cancers. For this, we will mine multiple transcriptome datasets and develop a variety of supervised machine learning models to distinguish between YAPoff vs YAPon cancers. We will further evaluate the ability of these classifiers to be robust to multiple sources of noise across different cancer classes and empirically test them on clinical samples to refine the ideal binary classification scheme. This work is critical to guide optimal therapies and exploit the unique vulnerabilities of YAPoff and YAPon cancers.
Year: 2022
Researcher:
Kieran Campbell, Lunenfeld-Tanenbaum Research Institute
Student:
Cameron Dufault, McMaster University